Gordon A. Jamieson

Gordon A. Jamieson is the CEO and founder of Translational Therapeutics. Gordon has over 25 years of experience in the pharmaceutical and biotech industries. Prior to Translational Therapeutics, they were the CEO/President of Epigen Consulting, Inc. from 1997-2005. Gordon also held the position of Assistant Professor at the University of Cincinnati College of Medicine from 1989-1997. Gordon received their BS in Pharmacy from the University of Cincinnati and their PhD in Medicinal Chemistry from Purdue University.

Gordon A. Jamieson completed their undergraduate studies at Middlebury College, where they earned a B.A. in Biology-Chemistry. Gordon then went on to earn a Ph.D. in Microbiology and Immunology - Protein Chemistry from Duke University. Finally, they earned an M.B.A. in Marketing and Management of Advanced Technology and Innovation from the University of Cincinnati Carl H. Lindner College of Business.